Condition
Bone Metastases of a Malignant Tumor
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Completed2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07043608Phase 2Not Yet Recruiting
Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases
NCT07471022CompletedPrimary
Hemiarthroplasty for Elderly With Proximal Humeral Mets
NCT01179464Not ApplicableCompletedPrimary
Effect of Aminobiphosphonates and Statins on Circulating Vgamma9Vdelta2-T Cells
Showing all 3 trials